Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Pak

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Ophthalmology Science|December 24, 2025
Association between Baseline Subfoveal Choroidal Thickness and Anatomical and Functional Outcomes in Geographic AtrophyAlythia Vo, Liangbo Linus Shen, Irene Pak, et al.
Science Advances|September 9, 2022
Proteotype coevolution and quantitative diversity across 11 mammalian speciesQian Ba, Yuanyuan Hei, Anasuya Dighe, et al.
Plos One|March 24, 2016
A Rapid and Improved Method to Generate Recombinant Dengue Virus Vaccine CandidatesDhanasekaran Govindarajan, Liming Guan, Steven Meschino, et al.
Oncoimmunology|December 18, 2012
An efficient T-cell epitope discovery strategy using in silico prediction and the iTopia assay platformArthur Fridman, Adam C Finnefrock, Daniela Peruzzi, et al.
Infection and Drug Resistance|August 22, 2018
Characterization of hepatitis C virus resistance to grazoprevir reveals complex patterns of mutations following on-treatment breakthrough that are not observed at relapseDavid Bonsall, Stuart Black, Anita Ym Howe, et al.
Evolution, Medicine, and Public Health|September 23, 2022
Evolution of higher mesenchymal CD44 expression in the human lineage: A gene linked to cancer malignancyXinghong Ma, Anasuya Dighe, Jamie Maziarz, et al.
Human Gene Therapy|June 7, 2008
Therapeutic vaccination halts disease progression in BALB-neuT mice: the amplitude of elicited immune response is predictive of vaccine efficacyBarbara Cipriani, Arthur Fridman, Claus Bendtsen, et al.
Clinical Pharmacology and Therapeutics|November 14, 2019
A Machine-Learning Approach to Identify a Prognostic Cytokine Signature That Is Associated With Nivolumab Clearance in Patients With Advanced MelanomaRui Wang, Xiao Shao, Junying Zheng, et al.
JAMA Network Open|July 15, 2022
Acceptance of Simulated Adult Patients With Medicaid Insurance Seeking Care in a Cancer Hospital for a New Cancer DiagnosisVictoria A Marks, Walter R Hsiang, James Nie, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2015
Susceptibilities of genotype 1a, 1b, and 3 hepatitis C virus variants to the NS5A inhibitor elbasvirRong Liu, Stephanie Curry, Patricia McMonagle, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Ophthalmology Science|December 24, 2025
Association between Baseline Subfoveal Choroidal Thickness and Anatomical and Functional Outcomes in Geographic AtrophyAlythia Vo, Liangbo Linus Shen, Irene Pak, et al.
Science Advances|September 9, 2022
Proteotype coevolution and quantitative diversity across 11 mammalian speciesQian Ba, Yuanyuan Hei, Anasuya Dighe, et al.
Plos One|March 24, 2016
A Rapid and Improved Method to Generate Recombinant Dengue Virus Vaccine CandidatesDhanasekaran Govindarajan, Liming Guan, Steven Meschino, et al.
Oncoimmunology|December 18, 2012
An efficient T-cell epitope discovery strategy using in silico prediction and the iTopia assay platformArthur Fridman, Adam C Finnefrock, Daniela Peruzzi, et al.
Infection and Drug Resistance|August 22, 2018
Characterization of hepatitis C virus resistance to grazoprevir reveals complex patterns of mutations following on-treatment breakthrough that are not observed at relapseDavid Bonsall, Stuart Black, Anita Ym Howe, et al.
Evolution, Medicine, and Public Health|September 23, 2022
Evolution of higher mesenchymal CD44 expression in the human lineage: A gene linked to cancer malignancyXinghong Ma, Anasuya Dighe, Jamie Maziarz, et al.
Human Gene Therapy|June 7, 2008
Therapeutic vaccination halts disease progression in BALB-neuT mice: the amplitude of elicited immune response is predictive of vaccine efficacyBarbara Cipriani, Arthur Fridman, Claus Bendtsen, et al.
Clinical Pharmacology and Therapeutics|November 14, 2019
A Machine-Learning Approach to Identify a Prognostic Cytokine Signature That Is Associated With Nivolumab Clearance in Patients With Advanced MelanomaRui Wang, Xiao Shao, Junying Zheng, et al.
JAMA Network Open|July 15, 2022
Acceptance of Simulated Adult Patients With Medicaid Insurance Seeking Care in a Cancer Hospital for a New Cancer DiagnosisVictoria A Marks, Walter R Hsiang, James Nie, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2015
Susceptibilities of genotype 1a, 1b, and 3 hepatitis C virus variants to the NS5A inhibitor elbasvirRong Liu, Stephanie Curry, Patricia McMonagle, et al.
Pageof 2